Estimating tumor-specific total mRNA level predicts cancer outcomes
Researchers at The University of Texas MD Anderson Cancer Center have developed a new approach to quantify tumor-specific total mRNA levels from patient tumor samples, which contain both cancer and non-cancer cells. Using this technique on tumors from more than 6,500 patients across 15 cancer types, the researchers demonstrated that higher mRNA levels in cancer cells were associated with reduced patient survival. The study suggests this computational approach could permit large-scale analyses of tumor-specific total mRNA...